SARAH HUFFSTETLER: Open Payments
NPI 1629517834 · MARTIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 37 payments from 7 companies in 2025. Trend: 2023 $666 · 2024 $770 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $176 |
| Novo Nordisk Inc | 3 | $95 |
| PFIZER INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, Ozempic, QULIPTA, UBRELVY, NURTEC ODT, FARXIGA, REXULTI.
Industry payments across TN — which companies pay providers there.
